Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Cancers of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Study completedNCT02296684
What this trial is testing

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Cancer of Head and NeckHead and Neck CancerNeoplasms, Head and Neck+3 more
Washington University School of Medicine 67
Early research (Phase 1)Study completedNCT03491709
What this trial is testing

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

Who this might be right for
Colorectal Cancer
Dragonboat Biopharmaceutical Company Limited 18
Testing effectiveness (Phase 2)Study completedNCT00833261
What this trial is testing

Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Texas Southwestern Medical Center 37
Testing effectiveness (Phase 2)Study completedNCT00939627
What this trial is testing

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT06006169
What this trial is testing

BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 186
Early research (Phase 1)Study completedNCT02586207
What this trial is testing

Pembrolizumab in Combination With CRT for LA-SCCHN

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+4 more
Sanford Health 59
Large-scale testing (Phase 3)Study completedNCT01302834
What this trial is testing

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Who this might be right for
Head and Neck CancerPrecancerous Condition
Radiation Therapy Oncology Group 987
Testing effectiveness (Phase 2)Study completedNCT05271604
What this trial is testing

Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and NeckRecurrent Squamous Cell Carcinoma of the Head and Neck+2 more
BioAtla, Inc. 42
Large-scale testing (Phase 3)Looking for participantsNCT06194734
What this trial is testing

KC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Beijing Konruns Pharmaceutical Co., Ltd. 490
Testing effectiveness (Phase 2)Study completedNCT03194373
What this trial is testing

Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Michigan Rogel Cancer Center 21
Not applicableStudy completedNCT04672772
What this trial is testing

Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 531
Testing effectiveness (Phase 2)Active Not RecruitingNCT03813836
What this trial is testing

Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
University College, London 63
Early research (Phase 1)Ended earlyNCT02254044
What this trial is testing

Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus

Who this might be right for
Carcinoma, Squamous Cell
Boehringer Ingelheim 7
Not applicableStudy completedNCT00897052
What this trial is testing

Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 29
Testing effectiveness (Phase 2)Ended earlyNCT01192815
What this trial is testing

Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+9 more
Case Comprehensive Cancer Center 2
Early research (Phase 1)Study completedNCT00113347
What this trial is testing

Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT05420948
What this trial is testing

Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+2 more
University of Chicago 30
Testing effectiveness (Phase 2)Looking for participantsNCT06319963
What this trial is testing

Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Who this might be right for
HPV-Related Cervical CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Theravectys S.A. 72
Next Page